期刊论文详细信息
Journal of Biomedical Semantics
The pathway ontology – updates and applications
Howard J Jacob1  Elizabeth A Worthey1  Diane H Munzenmaier2  Melinda R Dwinell2  Mary Shimoyama4  Shur-Jen Wang3  Rajni Nigam3  Timothy F Lowry3  Stanley JF Laulederkind3  Jeff De Pons3  Jennifer R Smith3  G Thomas Hayman3  Marek Tutaj3  Pushkala Jayaraman3  Victoria Petri3 
[1] Department of Pediatrics, Medical College of Wisconsin, Milwaukee, WI, USA;Department of Physiology, Medical College of Wisconsin, Milwaukee, WI, USA;Human and Molecular Genetics Center, Medical College of Wisconsin, Milwaukee, WI, USA;Department of Surgery, Medical College of Wisconsin, Milwaukee, WI, USA
关键词: Pathway diagrams;    Pathway annotations;    Pipeline;    Ontology;    Biological pathway;   
Others  :  806116
DOI  :  10.1186/2041-1480-5-7
 received in 2013-05-21, accepted in 2013-12-05,  发布年份 2014
PDF
【 摘 要 】

Background

The Pathway Ontology (PW) developed at the Rat Genome Database (RGD), covers all types of biological pathways, including altered and disease pathways and captures the relationships between them within the hierarchical structure of a directed acyclic graph. The ontology allows for the standardized annotation of rat, and of human and mouse genes to pathway terms. It also constitutes a vehicle for easy navigation between gene and ontology report pages, between reports and interactive pathway diagrams, between pathways directly connected within a diagram and between those that are globally related in pathway suites and suite networks. Surveys of the literature and the development of the Pathway and Disease Portals are important sources for the ongoing development of the ontology. User requests and mapping of pathways in other databases to terms in the ontology further contribute to increasing its content. Recently built automated pipelines use the mapped terms to make available the annotations generated by other groups.

Results

The two released pipelines – the Pathway Interaction Database (PID) Annotation Import Pipeline and the Kyoto Encyclopedia of Genes and Genomes (KEGG) Annotation Import Pipeline, make available over 7,400 and 31,000 pathway gene annotations, respectively. Building the PID pipeline lead to the addition of new terms within the signaling node, also augmented by the release of the RGD “Immune and Inflammatory Disease Portal” at that time. Building the KEGG pipeline lead to a substantial increase in the number of disease pathway terms, such as those within the ‘infectious disease pathway’ parent term category. The ‘drug pathway’ node has also seen increases in the number of terms as well as a restructuring of the node. Literature surveys, disease portal deployments and user requests have contributed and continue to contribute additional new terms across the ontology. Since first presented, the content of PW has increased by over 75%.

Conclusions

Ongoing development of the Pathway Ontology and the implementation of pipelines promote an enriched provision of pathway data. The ontology is freely available for download and use from the RGD ftp site at ftp://rgd.mcw.edu/pub/ontology/pathway/ webcite or from the National Center for Biomedical Ontology (NCBO) BioPortal website at http://bioportal.bioontology.org/ontologies/PW webcite.

【 授权许可】

   
2014 Petri et al.; licensee BioMed Central Ltd.

【 预 览 】
附件列表
Files Size Format View
20140708090158980.pdf 2927KB PDF download
Figure 5. 108KB Image download
Figure 4. 166KB Image download
Figure 3. 157KB Image download
Figure 2. 91KB Image download
Figure 1. 99KB Image download
【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

Figure 5.

【 参考文献 】
  • [1]Rat Genome Database http://rgd.mcw.edu webcite
  • [2]Ashburner M, Lewis S: On ontologies for biologists: the gene ontology—untangling the web. Novartis Found Symp 2002, 247:66-80.
  • [3]Day-Richter J, Harris MA, Haendel M, Lewis S, Gene Ontology OBO-Edit Working Group: OBO-Edit—an ontology editor for biologists. Bioinformatics (Oxford, England) 2007, 23(16):2198-2200.
  • [4]Bodenreider O, Stevens R: Bio-ontologies: current trends and future directions. Brief Bioinform 2006, 7(3):256-274.
  • [5]Musen MA, Noy NF, Shah NH, Whetzel PL, Chute CG, Story M-A, Smith B, The NCBO team: The National Center for Biomedical ontology. J Am Med Inform Assoc 2012, 19(2):190-195.
  • [6]NCBO BioPortal http://www.bioportal.bioontology.org webcite
  • [7]Smith JR, Park CA, Nigam R, Laulederkind SJF, Hayman GT, Wang S-J, Lowry TF, Petri V, Pons J, Tutaj M, Liu W, Worthey EA, Shimoyama M, Dwinell MR: The clinical measurement, measurement method and experimental condition ontologies: expansion, improvements and new applications. J Biomed Semantics “Biomedical Ontologies” thematic series 2013, 4(1):26.
  • [8]KEGG: Kyoto Encyclopedia of Genes and Genomes http://www.genome.jp/kegg/ webcite
  • [9]The Pharmacogenomics Database [PharmGKB] http://www.pharmgkb.org webcite
  • [10]The Small Molecule Pathway Database (SMPDB) http://www.smpdb.ca webcite
  • [11]WikiPathways http://www.wikipathways.org/index.php/WikiPathways webcite
  • [12]Petri V: Pathway resources at the Rat Genome Database. In Handbook of Research on Computational and Systems Biology: Interdisciplinary Applications. Edited by Liu LA, Wei DQ, Li Y, Lei H. New York: Hershey; 2011:316-336.
  • [13]Copeland NG, Jenkins NA: Deciphering the genetic landscape of cancer – from genes to pathways. Trends Genet 2009, 25(10):455-462.
  • [14]Wang E: Understanding genomic alterations in cancer genomes using an integrative network approach. Cancer Lett 2012. http://dx.doi.org/10.1016/j.canlet.2012.11.050 webcite
  • [15]Garraway LA, Lander ES: Lessons from the cancer genome. Cell 2013, 153(1):17-37.
  • [16]Jones E, Zhang X, Parsons DW, Lin JC, Leary RJ, Angenendt P, Mankoo P, Carter H, Kamiyama H, Jimeno A, Hong SM, Fu B, Lin MT, Calhoun ES, Kamiyama M, Walter K, Nikolskaya Y, Nilkolsky Y, Hartigan J, Smith DR, Hidalgo M, Leach SD, Klein AP, Jaffee EM, Goggins M, Maitra A, Iacobuzio-Donahue C, Eshleman JR, Kern SE, Hruban RH, et al.: Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science 2008, 321(5897):1801-1806.
  • [17]Petri V, Shimoyama M, Hayman GT, Smith JR, Tutaj M, De Pons J, Dwinell MR, Munzenmaier DH, Twigger SN, Jacob HJ, RGD Team: The Rat Genome database pathway portal. Database(Oxford) 2011, 8:bar010.
  • [18]Hayman GT, Jayaraman P, Petri V, Tutaj M, Liu W, De Pons J, Dwinell MR, Shimoyama M, Worthey E, Munzenmaier DH, Jacob HJ: The updated RGD pathway portal utilizes increased curation efficiency and provides expanded pathway information. Hum Genomics 2013. doi:10.1186/1479-7364-7-4
  • [19]Dwinell MR, Worthey EA, Shimoyama M, Bakir-Gungor B, De Pons J, Laulederkind S, Lowry T, Nigam R, Petri V, Smith J, Stoddard A, Twigger SN, Jacob HJ, RGD Team: The Rat Genome Database 2009: variation, ontologies and pathways. Nucleic Acids Res 2009, 37(Database issue):D744-749.
  • [20]Laulederkind SJ, Hayman GT, Wang SJ, Smith JR, Lowry TF, Nigam R, Petri V, De Pons J, Dwinell MR, Shimoyama M: The Rat Genome Database 2013—data, tools and users. Brief Bioinform 2013, 14(4):520-526.
  • [21]Schaefer CF, Anthony K, Krupa S, Buchoff J, Day M, Hannay T, Buetow KH: PID: the Pathway Interaction Database. Nucleic Acids Res 2009, 37(Database Issue):D674-679.
  • [22]Kanehisa M, Goto S, Furumichi M, Tanabe M, Hirakawa M: KEGG for representation and analysis of molecular networks involving diseases and drugs. Nucleic Acids Res 2010, 38(Database issue):D355-360.
  • [23]Kanehisa M, Goto S, Sato Y, Furumichi M, Tanabe M: KEGG for integration and interpretation of large-scale molecular data sets. Nucleic Acids Res 2012, 40(Database issue):D109-114.
  • [24]WHO Collaborating Centre for Drug Statistics Methodology http://www.sciencedirect.com/science/article/pii/S0304383512007124 webcite
  • [25]World Health Organization http://www.who.int/en/ webcite
  • [26]KEGG DRUG - drugs [ATC drug classification] http://www.genome.jp/kegg-bin/get_htext?br08303.keg webcite
  • [27]Ingelman-Sundberg M: Human drug metabolizing cytochrome P450 enzymes: properties and polymorphism. Naunyn Schmiedebergs Arch Pharmacol 2004, 369(1):89-104.
  • [28]Guengerich FP: Cytochrome P450s and other enzymes in drug metabolism and toxicity. AAPS J 2006, 8(1):E101-111.
  • [29]OBO-edit: the OBO ontology editor http://oboedit.org/ webcite
  • [30]Pathway ontology ftp site at RGD ftp://rgd.mcw.edu/pub/ontology/pathway/ webcite
  • [31]Pathway ontology at NCBO BioPortal http://bioportal.bioontology.org/ontologies/1035 webcite
  • [32]Pathway studio http://bioportal.bioontology.org/ontologies/PW webcite
  • [33]Walls C, Breidenbach R: Spring in Action. 2nd edition. Greenwich: Manning Publication; 2007.
  • [34]Apache log4j http://logging.apache.org/log4j/1.2/ webcite
  文献评价指标  
  下载次数:33次 浏览次数:12次